Sign Out
Allora Syrup: Mild to moderate: Adult: Somnolence, tachycardia, and headache have been reported in overdose (range 40 to 180 mg).
Children: Extrapyramidal signs and palpitations have been reported in children following doses of greater than 10 mg.
Severe: Prolonged QT interval and Torsades de pointes (TDP) and/or ventricular tachycardia (VT) have been reported after therapeutic use, and might occur after overdose. Most of these patients had other risk factor for TDP or VT.
Treatment: Treatment is symptomatic and supportive. Prehospital gastrointestinal decontamination is not routinely required. Consider activated charcoal if the overdose is very large, recent, the patient is not vomiting, and is able to maintain airway.
Continue with Google